IPP Bureau

TAKE divests stake in Navitas Life Sciences to HIG
TAKE divests stake in Navitas Life Sciences to HIG

By IPP Bureau - August 08, 2021

The transaction is expected to close in the Q4FY22

Cipla posts  net profit at Rs 715 crores
Cipla posts net profit at Rs 715 crores

By IPP Bureau - August 08, 2021

India business contributes to a stellar performance

Divi's Labs posts a 13 per cent rise in PAT at Rs 557.11 crore
Divi's Labs posts a 13 per cent rise in PAT at Rs 557.11 crore

By IPP Bureau - August 08, 2021

Forex gains stood at Rs 20 crore for the quarter

Alkem launches Ibuprofen and Famotidine tablets in US
Alkem launches Ibuprofen and Famotidine tablets in US

By IPP Bureau - August 07, 2021

Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg

Sanofi to acquire Translate Bio
Sanofi to acquire Translate Bio

By IPP Bureau - August 07, 2021

Advances deployment of mRNA technology across vaccines and therapeutics development

Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr
Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr

By IPP Bureau - August 07, 2021

This robust growth has come despite the raging pandemic for most part of the quarter

SPI Pharma partners Azelis Americas
SPI Pharma partners Azelis Americas

By IPP Bureau - August 07, 2021

In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace

Stelis Biopharma appoints Mark W. Womack as CEO
Stelis Biopharma appoints Mark W. Womack as CEO

By IPP Bureau - August 07, 2021

He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations

Strides to acquire US manufacturing facility of Endo for $24 mn
Strides to acquire US manufacturing facility of Endo for $24 mn

By IPP Bureau - August 06, 2021

The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.

Mark W. Womack is the new CEO of Stelis Biopharma
Mark W. Womack is the new CEO of Stelis Biopharma

By IPP Bureau - August 06, 2021

He will be stationed at the company HQ in Bengaluru, India

Govt augments PSEs and Bharat Biotech to ramp up Covaxin production
Govt augments PSEs and Bharat Biotech to ramp up Covaxin production

By IPP Bureau - August 06, 2021

CDSCO to fast-track trials and approval for COVID19 vaccine

India’s gets its first bio-bank for heart failure research
India’s gets its first bio-bank for heart failure research

By IPP Bureau - August 06, 2021

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology

Scientists from BRICS work on genomic sequencing of Covid-19
Scientists from BRICS work on genomic sequencing of Covid-19

By IPP Bureau - August 06, 2021

Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread

Dr. Reddy's Laboratories signs asset purchase agreement with BioDelivery Sciences
Dr. Reddy's Laboratories signs asset purchase agreement with BioDelivery Sciences

By IPP Bureau - August 05, 2021

Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing

Apollo Hospitals successfully implants MitraClip
Apollo Hospitals successfully implants MitraClip

By IPP Bureau - August 05, 2021

MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery

Latest Stories

Interviews

Packaging